Accredited CME programs are no longer the only legally sanctioned forum for education about off-label uses of drugs and medical devices. In a July 30 decision, U.S. District Judge Royce C. Lamberth ruled that FDA regulations that prohibit drug and device companies from disseminating information about off-label uses are a violation of the manufacturers' commercial speech rights. The Washington Legal Foundation, a nonprofit public interest law and policy center that objects to government ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only gain access to Printer-friendly, you'll get exclusive access to a large archive of premium content.

Already registered? here.